Journal Of Cancer Research And Therapeutics

SCI SCIE

国际简称：J CANCER RES THER 参考译名：癌症研究与治疗学杂志

主要研究方向：ONCOLOGY 非预警期刊审稿周期：约6月

《癌症研究与治疗学杂志》(Journal Of Cancer Research And Therapeutics)是一本由Wolters Kluwer Medknow Publications出版的以ONCOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q4 JCR分区
222 年发文量
1.4 IF影响因子
开放是否OA
30 H-index
2005 创刊年份
Quarterly 出版周期
English 出版语言

The journal will cover technical and clinical studies related to health, ethical and social issues in field of Medical oncology, radiation oncology, medical imaging, radiation protection, non-ionising radiation, radiobiology. Articles with clinical interest and implications will be given preference.

[ 查看全部 ]

投稿咨询加急咨询

Journal Of Cancer Research And Therapeutics期刊信息

ISSN：0973-1482
出版语言：English
是否OA：开放
E-ISSN：0974-1127
出版地区：INDIA
是否预警：否
出版商：Wolters Kluwer Medknow Publications
出版周期：Quarterly
创刊时间：2005
开源占比：0.9336
Gold OA文章占比：100.00%
OA被引用占比：0.0007...
出版国人文章占比：0.39
出版撤稿占比：0
研究类文章占比：91.44%

Journal Of Cancer Research And Therapeutics CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

2.3

0.425

0.553

学科类别	分区	排名	百分位
大类：Medicine 小类：Radiology, Nuclear Medicine and Imaging	Q3	209 / 361	42%
大类：Medicine 小类：Oncology	Q3	285 / 428	33%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Journal Of Cancer Research And Therapeutics中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	ONCOLOGY 肿瘤学	4区

Journal Of Cancer Research And Therapeutics JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q4	287 / 333	14
学科：ONCOLOGY	SCIE	Q4	291 / 333	12.76

Journal Of Cancer Research And Therapeutics历年数据统计

影响因子

中科院分区

Journal Of Cancer Research And Therapeutics中国学者发文选摘

1、An analysis of the clinical efficacy and safety of a temperature-sensitive liquid embolic agent loaded with lobaplatin for the treatment of unresectable primary hepatocellular carcinoma through chemoembolizatio
Author: Zhou, Shengyu; Lin, Qingfeng; Zhong, Junsheng; Chen, Jian

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 504-508. DOI: 10.4103/jcrt.jcrt_2250_24
2、Supine/prone position fixation treatment in cervical cancer radiotherap
Author: Zheng, Zhiman; Liu, Dongyue; Su, Yangmei

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 401-408. DOI: 10.4103/jcrt.jcrt_2050_24
3、MSNs-loaded HMME and Erastin-mediated ferroptosis combined with sonodynamic therapy for HCC treatmen
Author: Zhao, Chang; Qin, Guchun; Ling, Caixia; Zhao, Yang; Huang, Yunxi; Jiang, Zelong; Zhou, Niqiang; Liu, Junjie; Su, Danke; Jiang, Jinghang

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. -. DOI: 10.4103/jcrt.jcrt_1531_24
4、Deep learning model for predicting the RAS oncogene status in colorectal cancer liver metastase
Author: Zhang, Baogen; Wang, Kai; Xu, Ting; Zhu, Haibin; Wang, Kangjie; Wang, Jing; Xiang, Yaoxian; He, Xuelei; Zhu, Siyu; An, Chao; Yan, Dong

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. -. DOI: 10.4103/jcrt.jcrt_1910_24
5、Advancing colorectal cancer diagnosis: The role of tumor-derived serum galanin and haptoglobin as novel biomarker
Author: Yuan, Ning; Ren, Ren; Li, Dan; Liang, Xinmei; Pang, Xiaochen; Wang, Jun; Feng, Xiaodong; Zhang, Zhijun

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 417-424. DOI: 10.4103/jcrt.jcrt_1742_24
6、Impact of materia medica in combination with transarterial chemoembolization on inflammatory markers in patients with hepatocellular carcinoma: A systematic review and meta-analysi
Author: Yu, Chengyang; Yu, Yifan; Wang, Xiongwen

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. -. DOI: 10.4103/jcrt.jcrt_1954_24
7、A study on the safety and efficacy of a robotic-assisted navigation and positioning system in CT-guided percutaneous biopsy of thoracic and abdominal tumor
Author: You, Xiang; Zhu, Xiaoli; Chen, Qingjie; Chen, Jin; Lin, Huihuang; Huang, Bingyu; Yang, Dongyong; Hu, Hongjie; Lin, Zhengyu

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 389-394. DOI: 10.4103/jcrt.jcrt_1888_24
8、Oral and intestinal flora translocation and tumor developmen
Author: Ye, Zhiyuan; Gao, Linglin; Guo, Zhi; Wang, Qiang

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 323-333. DOI: 10.4103/jcrt.jcrt_50_24